Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Diabete Type 2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clinical Trials Unit, Chinese University of Hong Kong, Hong Kong, Hong Kong
Contact: Study coordinator (Elaine Chow, MD)

Study leads

Elaine YK Chow
Principal Investigator
Chinese University of Hong Kong
Juliana CN Chan
Principal Investigator
Chinese University of Hong Kong

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Type 2 Diabetes

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Santa Ana, United States

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Obesity · Overweight · Diabetes Mellitus, Type 2

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Phoenix, United States

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus · T2DM

Abroad (travel likely)RecruitingPHASE2

Mesa, United States · Orlando, United States

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Type II Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · Hialeah Gardens, United States